Vimarsana
Biggest News Aggregation in the World

Page 6 - Sera Prognostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sera Prognostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sera Prognostics Today - Breaking & Trending Today

Contrasting BioNexus Gene Lab (NASDAQ:BGLC) and Sera Prognostics (NASDAQ:SERA) - Vimarsana News

Contrasting BioNexus Gene Lab (NASDAQ:BGLC) and Sera Prognostics (NASDAQ:SERA)

BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) and Sera Prognostics (NASDAQ:SERA – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk and institutional ownership. Profitability This table compares BioNexus Gene […]

Source: wkrb13.com
BioNexus Gene Lab (NASDAQ:BGLC) vs. Sera Prognostics (NASDAQ:SERA) Critical Review - Vimarsana News

BioNexus Gene Lab (NASDAQ:BGLC) vs. Sera Prognostics (NASDAQ:SERA) Critical Review

BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) and Sera Prognostics (NASDAQ:SERA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, institutional ownership and valuation. Profitability This table compares BioNexus Gene […]

SERA PROGNOSTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS - Vimarsana News

SERA PROGNOSTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative...

Head to Head Comparison: Sera Prognostics (NASDAQ:SERA) versus MedTech Acquisition (NASDAQ:MTAC) - Vimarsana News

Head to Head Comparison: Sera Prognostics (NASDAQ:SERA) versus MedTech Acquisition (NASDAQ:MTAC)

Sera Prognostics (NASDAQ:SERA – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability. Valuation & Earnings This table compares Sera […]

Source: wkrb13.com
Riverview Capital Advisers LLC Boosts Stock Holdings in Sera Prognostics, Inc. (NASDAQ:SERA) - Vimarsana News

Riverview Capital Advisers LLC Boosts Stock Holdings in Sera Prognostics, Inc. (NASDAQ:SERA)

Riverview Capital Advisers LLC lifted its holdings in shares of Sera Prognostics, Inc. (NASDAQ:SERA – Free Report) by 5.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 102,731 shares of the company’s stock after buying an additional 5,563 shares during the quarter. […]